Loading company…
WISBiOM develops microbiome products and live biopharmaceuticals focused on the bacteria-gut-brain axis.
Founded in 2021 and based in Beijing, WISBiOM develops products based on breast milk-origin bacteria for children's growth and development. Its work includes microbiological agents, live biopharmaceuticals, microbiome assays, and high-throughput screening and analysis tools for anaerobic bacteria. The company closed a pre-Series A funding round in December 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in